Technical Analysis for ADMA - ADMA Biologics Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 9.10 | -0.66% | -0.06 |
ADMA closed down 0.66 percent on Wednesday, May 15, 2024, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| New 52 Week Closing High | Bullish | -0.66% | |
| New 52 Week High | Strength | -0.66% | |
| Upper Bollinger Band Walk | Strength | -0.66% |
| Alert | Time |
|---|---|
| Down 1% | about 10 hours ago |
| 60 Minute Opening Range Breakdown | about 10 hours ago |
| 1.5x Volume Pace | about 11 hours ago |
| Rose Above Previous Day's High | about 11 hours ago |
| New 52 Week High | about 11 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. RI-002 is an injectable immune globulin derived from human plasma enriched with high levels of naturally occurring polyclonal antibodies, as well as high levels of antibodies targeted to respiratory syncytial virus. The company also operates ADMA BioCenters, which are plasma collection centers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Biology Immunology Immune System Infectious Diseases Antibodies Antibody Glycoproteins Polyclonal Antibodies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Biology Immunology Immune System Infectious Diseases Antibodies Antibody Glycoproteins Polyclonal Antibodies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.33 |
| 52 Week Low | 3.06 |
| Average Volume | 2,884,843 |
| 200-Day Moving Average | 4.79 |
| 50-Day Moving Average | 6.57 |
| 20-Day Moving Average | 7.07 |
| 10-Day Moving Average | 7.70 |
| Average True Range | 0.35 |
| RSI (14) | 86.30 |
| ADX | 39.38 |
| +DI | 52.88 |
| -DI | 5.76 |
| Chandelier Exit (Long, 3 ATRs) | 8.29 |
| Chandelier Exit (Short, 3 ATRs) | 6.95 |
| Upper Bollinger Bands | 9.02 |
| Lower Bollinger Band | 5.13 |
| Percent B (%b) | 1.02 |
| BandWidth | 55.04 |
| MACD Line | 0.65 |
| MACD Signal Line | 0.38 |
| MACD Histogram | 0.2709 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.52 | ||||
| Resistance 3 (R3) | 9.55 | 9.44 | 9.45 | ||
| Resistance 2 (R2) | 9.44 | 9.33 | 9.43 | 9.43 | |
| Resistance 1 (R1) | 9.27 | 9.27 | 9.22 | 9.24 | 9.40 |
| Pivot Point | 9.16 | 9.16 | 9.13 | 9.15 | 9.16 |
| Support 1 (S1) | 8.99 | 9.05 | 8.94 | 8.96 | 8.80 |
| Support 2 (S2) | 8.88 | 8.99 | 8.87 | 8.77 | |
| Support 3 (S3) | 8.71 | 8.88 | 8.75 | ||
| Support 4 (S4) | 8.68 |
